Berkeley Lights to Participate in the Morgan Stanley Global Healthcare Conference

Rhea-AI Summary

Berkeley Lights (Nasdaq: BLI) will participate virtually in the Morgan Stanley Global Healthcare Conference on September 9, 2021. The management is scheduled for a fireside chat at 7:15 a.m. PT / 10:15 a.m. ET. A live and archived webcast will be accessible through the company's website under the 'Investors' section.

Berkeley Lights specializes in Digital Cell Biology, offering advanced solutions for developing biotherapeutics. Its platform provides comprehensive analysis of single cells, enhancing the rapid commercialization of cell-based products.

EMERYVILLE, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating virtually in the upcoming Morgan Stanley Global Healthcare Conference.

Berkeley Lights’ management is scheduled to participate in a fireside chat on Thursday, September 9 at 7:15 a.m. Pacific Time / 10:15 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.berkeleylights.com.

About Berkeley Lights
Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.

Berkeley Lights’ Beacon and Lightning systems and Culture Station instrument are: FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.

Press Contact
christy.nguyen@berkeleylights.com

Investor Contact
ir@berkeleylights.com

FAQ

When is Berkeley Lights participating in the Morgan Stanley Global Healthcare Conference?

Berkeley Lights will participate on September 9, 2021, at 7:15 a.m. Pacific Time.

How can I access Berkeley Lights' presentation at the conference?

The presentation can be accessed live and archived on the company's website in the 'Investors' section.

What is the focus of Berkeley Lights?

Berkeley Lights focuses on Digital Cell Biology, enabling the rapid development of biotherapeutics and cell-based products.

What type of information does the Berkeley Lights Platform provide?

The platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel.

What systems does Berkeley Lights offer for research?

Berkeley Lights offers the Beacon, Lightning systems, and Culture Station instrument, which are for research use only.